Pulmonary fibrosis as a result of acute lung inflammation: molecular mechanisms, relevant in vivo models, prognostic and therapeutic approaches
IA Savin, MA Zenkova, AV Sen'kova - International journal of molecular …, 2022 - mdpi.com
Pulmonary fibrosis is a chronic progressive lung disease that steadily leads to lung
architecture disruption and respiratory failure. The development of pulmonary fibrosis is …
architecture disruption and respiratory failure. The development of pulmonary fibrosis is …
[HTML][HTML] Diagnosis and treatment of acute pulmonary inflammation in critically ill patients: the role of inflammatory biomarkers
S Chalmers, A Khawaja, PM Wieruszewski… - World journal of …, 2019 - ncbi.nlm.nih.gov
Pneumonia and acute respiratory distress syndrome are common and important causes of
respiratory failure in the intensive care unit with a significant impact on morbidity, mortality …
respiratory failure in the intensive care unit with a significant impact on morbidity, mortality …
[HTML][HTML] β-Glucan extracts from the same edible shiitake mushroom Lentinus edodes produce differential in-vitro immunomodulatory and pulmonary cytoprotective …
Coronavirus pneumonia is accompanied by rapid virus replication, where a large number of
inflammatory cell infiltration and cytokine storm may lead to acute lung injury, acute …
inflammatory cell infiltration and cytokine storm may lead to acute lung injury, acute …
Epidemiology, mechanical power, and 3-year outcomes in acute respiratory distress syndrome patients using standardized screening. An observational cohort study
KKS Parhar, K Zjadewicz, A Soo, A Sutton… - Annals of the …, 2019 - atsjournals.org
Rationale: Limited data on the epidemiology of acute respiratory distress syndrome (ARDS)
using a standardized screening program exist. Objectives: To describe the population-based …
using a standardized screening program exist. Objectives: To describe the population-based …
COVID-19-related ARDS: key mechanistic features and treatments
Acute respiratory distress syndrome (ARDS) is a heterogeneous syndrome historically
characterized by the presence of severe hypoxemia, high-permeability pulmonary edema …
characterized by the presence of severe hypoxemia, high-permeability pulmonary edema …
Immunomodulatory activity of β-glucan polysaccharides isolated from different species of mushroom–A potential treatment for inflammatory lung conditions
Acute respiratory distress syndrome (ARDS) is the most common form of acute severe
hypoxemic respiratory failure in the critically ill with a hospital mortality of 40%. Alveolar …
hypoxemic respiratory failure in the critically ill with a hospital mortality of 40%. Alveolar …
New insights into clinical and mechanistic heterogeneity of the acute respiratory distress syndrome: summary of the Aspen Lung Conference 2021
TR Martin, RL Zemans, LB Ware… - American journal of …, 2022 - atsjournals.org
Clinical and molecular heterogeneity are common features of human disease.
Understanding the basis for heterogeneity has led to major advances in therapy for many …
Understanding the basis for heterogeneity has led to major advances in therapy for many …
A potential new pathway for heparin treatment of sepsis-induced lung injury: inhibition of pulmonary endothelial cell pyroptosis by blocking hMGB1-LPS-induced …
R Yang, X Zhang - Frontiers in Cellular and Infection Microbiology, 2022 - frontiersin.org
Sepsis is a significant cause of mortality in critically ill patients. Acute lung injury (ALI) is a
leading cause of death in these patients. Endothelial cells exposed to the bacterial …
leading cause of death in these patients. Endothelial cells exposed to the bacterial …
[HTML][HTML] Antibiotics as immunomodulators: a potential pharmacologic approach for ARDS treatment
A Sauer, K Peukert, C Putensen… - European Respiratory …, 2021 - Eur Respiratory Soc
First described in the mid-1960s, acute respiratory distress syndrome (ARDS) is a life-
threatening form of respiratory failure with an overall mortality rate of approximately 40 …
threatening form of respiratory failure with an overall mortality rate of approximately 40 …
Advancing precision medicine for the diagnosis and treatment of acute respiratory distress syndrome
AN Rizzo, NR Aggarwal, BT Thompson… - Journal of Clinical …, 2023 - mdpi.com
Acute respiratory distress syndrome (ARDS) is a common and life-threatening cause of
respiratory failure. Despite decades of research, there are no effective pharmacologic …
respiratory failure. Despite decades of research, there are no effective pharmacologic …